The diverse and talented Scientific Program Committee (SPC) is doing incredible work to bring you a 2020 VirtualCongress packed full of innovative and engaging content and educational opportunities
Ted T.M. Lee, MD, 2020 Scientific Program Chair
Director of Minimally Invasive Gynecologic Surgery, Magee-Womens Hospital, UPMC and Clinical
Professor, University of Pittsburgh School of Medicine, Pittsburgh, PA
Jaime Albornoz, MD
Member, Unit of Reproductive Medicine, Clinica Las Condes, Santiago, Chile
Pere N. Barri Soldevila, MD
Head of Department of Obstetrics, Gynecology and ART, Hospital Universitario Dexeus, Barcelona, Spain
Nisse V. Clark, MD, MPH
Site Director, Minimally Invasive Gynecologic Surgery, Massachusetts General Hospital, Boston, MA
Nash S. Moawad, MD, MS, FACOG, FACS
Chief Associate Professor, Division of Minimally-Invasive Gynecologic Surgery,
Department of Obstetrics & Gynecology, University of Florida, Gainesville, FL
Samar Nahas, MD, MPH
Chair, Department of Obstetrics & Gynecology, UC Riverside School of Medicine, Riverside, CA
Linda C. Yang, MD, MS
Assistant Professor, Department of Obstetrics & Gynecology, Loyola University Medical Center,
Johnny Yi, MD
Assistant Professor, Fellowship Program Director and Urogynecologist, Department of Medical and
Surgical Gynecology, Mayo Clinic Arizona, Phoenix, AZ
Jubilee Brown, MD, Consultant
Dr. Brown is Professor and Associate Director of the Department of Gynecologic Oncology, Levine Cancer institute at Atrium Health and Clinical Professor at the University of North Carolina – Chapel Hill. Prior to that appointment, she was a tenured Professor at the University of Texas M.D. Anderson Cancer Center, where she worked for 17 years. She is a board-certified gynecologic oncologist.
Dr. Brown is an expert in minimally invasive (laparoscopic and robotic) surgery and has trained physicians worldwide in these techniques. She has published widely in minimally invasive surgery, contained extraction, and rare tumors. Her work lead to the National Comprehensive Cancer Network ® (NCCN®) recommendations for modified staging in stromal ovarian tumors. She has been the principal investigator on one completed and one ongoing GOG/NRG trial. Dr. Brown has published over 75 peer reviewed publications, authored 15 chapters, and has edited an award-winning textbook on rare tumors. She has lectured on 5 continents and has contributed to leadership in the AAGL.
Linda D. Bradley, MD, Medical Director
Dr. Bradley is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine and Director of the Center for Menstrual Disorders and Fibroids.She recently was appointed Medical Director of the AAGL.
Dr. Bradley earned a Bachelor’s degree from Vassar College before attending the University of Cincinnati College of Medicine for her M.D.She completed her residency training at Case Western Reserve University in Cleveland, Ohio. She is an internationally recognized gynecologic surgeon known for her expertise in diagnostic and operative hysteroscopy, fibroids and alternatives to hysterectomy.